Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage

A majority of Canadian groups that submitted comments about pending government coverage for medicines held conflicts with drug makers.

More From BioPortfolio on "Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage"